Hôtel-Dieu

corporate_fareorganization

Hôtel-Dieu

- Funding / Projects
  (19)

19 Projects, page 1 of 4

Impact of respiratory viral infections through TLR7 signaling on tumor progression and resistance to chemo- and immunotherapy in lung cancers
assignment_turned_inProject2016 - 2019Partners:Université Denis Diderot Paris 7, Hôtel-Dieu, Institut Curie, CNRS INSERM UMRS872
Université Denis Diderot Paris 7,
Hôtel-Dieu,
Institut Curie,
CNRS INSERM UMRS872
Funder: Institut National du Cancer Project Code: INCa-10694
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Unité « centre d’essais précoces en cancérologie (CEPEC) » du service d’oncologie médicale de l’hôpital européen Georges Pompidou
assignment_turned_inProject2011 - 2015Partners:Hôtel-Dieu, Xentech, Hôpital Européen Georges Pompidou (HEGP) - AP-HP, Groupe Hospitalier Cochin
Hôtel-Dieu,
Xentech,
Hôpital Européen Georges Pompidou (HEGP) - AP-HP,
Groupe Hospitalier Cochin
Funder: Institut National du Cancer Project Code: INCa-3550
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
"Impact des « spin » sur l’interprétation des résumés des essais randomisés publiés en cancérologie/Impact of """"spin"""" on the interpretation of results of randomized trials in oncology"
assignment_turned_inProjectPartners:Hôtel-Dieu, Ethox Centre and Wellcome Centre for Ethics and Humanities - UUniversity of Oxford, Hôpital Ambroise Paré
Hôtel-Dieu,
Ethox Centre and Wellcome Centre for Ethics and Humanities - UUniversity of Oxford,
Hôpital Ambroise Paré
Funder: Institut National du Cancer Project Code: INCa-DGOS-2428
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
assignment_turned_inProjectPartners:Hôtel-Dieu
Hôtel-Dieu
Funder: Institut National du Cancer Project Code: INCa-DGOS-8415
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Etude randomisée internationale de phase III comparant une chimiothérapie empirique par cisplatine et gemcitabine à un traitement « à la carte » orienté par le cancer primitif suspecté par une analyse moléculaire chez les patients atteints de carcinomes de primitifs inconnus (GEFCAPI 04). GEFCAPI 04: A randomised trial comparing an empiric chemotherapy (cisplatin-gemcitabine) to an « à la carte » treatment according to the primary suspected by molecular analysis in patients with a carcinoma of unknown primary (CUP).
assignment_turned_inProjectPartners:University Hospital, Maastricht, Centre Oscar Lambret, Hôtel-Dieu, Centre Eugène Marquis, ORGANISME NON ASSOCIE +5 partners
University Hospital, Maastricht,
Centre Oscar Lambret,
Hôtel-Dieu,
Centre Eugène Marquis,
ORGANISME NON ASSOCIE,
Groupe Hospitalier Henri Mondor - Albert Chenevier,
Karolinska Institutet,
Institut de Cancérologie de Lorraine,
Institut Gustave Roussy,
Centre Hospitalier Universitaire de Saint-Étienne
Funder: Institut National du Cancer Project Code: INCa-DGOS-2446
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
chevron_right

Hôtel-Dieu

Hôtel-Dieu

19 Projects, page 1 of 4

Impact of respiratory viral infections through TLR7 signaling on tumor progression and resistance to chemo- and immunotherapy in lung cancers

Unité « centre d’essais précoces en cancérologie (CEPEC) » du service d’oncologie médicale de l’hôpital européen Georges Pompidou

"Impact des « spin » sur l’interprétation des résumés des essais randomisés publiés en cancérologie/Impact of """"spin"""" on the interpretation of results of randomized trials in oncology"

Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs

Loading